Package Leaflet: Information for the Patient
Yasnal 10 mg Film-Coated Tablets EFG
Donepezil Hydrochloride
Read the entire package leaflet carefully before you start taking this medicine, because it contains important information for you.
Contents of the Package Leaflet
Yasnal (donepezil hydrochloride) contains the active substance donepezil hydrochloride. Yasnal (donepezil hydrochloride) belongs to a group of medicines called acetylcholinesterase inhibitors. Donepezil increases the levels in the brain of a substance related to memory (acetylcholine), by reducing the speed of breakdown of this substance.
It is used for the treatment of the symptoms of dementia in people who have been diagnosed with mild to moderately severe Alzheimer's disease. These symptoms include memory loss, confusion, and changes in behavior. As a result, patients with Alzheimer's disease find it increasingly difficult to carry out their normal daily activities.
Yasnal is used only in adults.
Do not take Yasnal
Warnings and Precautions
Talk to your doctor or pharmacist before taking Yasnal if you have or have had:
Talk to your doctor if you are pregnant or think you might be pregnant.
Children and Adolescents
Yasnal is not recommended for use in children and adolescents (under 18 years of age).
Other Medicines and Yasnal
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription. This also includes medicines that you might take in the future if you continue to take Yasnal. The reason is that these medicines may increase or decrease the effect of Yasnal.
It is especially important that you tell your doctor if you are taking any of the following medicines:
If you are going to have surgery that requires general anesthesia, you must inform your doctor and anesthesiologist that you are taking Yasnal. The reason is that this medicine may affect the amount of anesthesia needed.
Yasnal can be used in patients with kidney or liver disease, mild or moderate. Inform your doctor if you have kidney or liver disease. Patients with severe liver disease should not take Yasnal.
Tell your doctor or pharmacist the name of your caregiver. This person will help you take your medication as prescribed.
Taking Yasnal with Food, Drinks, and Alcohol
Food does not affect the effect of Yasnal.
Yasnal should not be taken with alcohol because alcohol may change its effect.
Pregnancy, Breast-feeding, and Fertility
If you are pregnant or breast-feeding, think you might be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
If you are breast-feeding, you should not take this medicine.
Driving and Using Machines
Alzheimer's disease may affect your ability to drive or use machines, and you should not carry out these activities unless your doctor tells you it is safe to do so.
Additionally, this medicine may cause tiredness, drowsiness, and muscle cramps. If you experience any of these effects, do not drive or use machines.
Yasnal Contains Lactose
If your doctor has told you that you have an intolerance to some sugars, consult your doctor before taking this medicine.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
How Much Yasnal Should You Take
The recommended initial dose is 5 mg (one white tablet) each night.
If you have abnormal dreams, nightmares, or difficulty sleeping (see section 4), your doctor may recommend that you take this medicine in the morning.
After one month of treatment, your doctor may increase your dose to one 10 mg tablet (one yellow tablet) each night.
The dose you take may vary depending on how long you have been taking this medicine and what your doctor recommends. The maximum recommended dose is 10 mg each night.
Always follow the advice of your doctor or pharmacist on how much and when to take your medication. Do not change this dose without consulting your doctor.
How to Take Your Medicine
Swallow your Yasnal tablet with a glass of water before going to bed.
Use in Children and Adolescents
Yasnal is not recommended for use in children and adolescents (under 18 years of age).
If You Take More Yasnal Than You Should
Contact your doctor or the emergency department of the nearest hospital immediately if you take more medicine than you should. Bring this package leaflet and any remaining tablets with you.
Symptoms of overdose may include nausea (feeling sick) and vomiting (being sick), drooling, sweating, slow heartbeat, decreased blood pressure (mild headache or dizziness when standing up), difficulty breathing, fainting, and seizures.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, stating the medicine and the amount taken.
If You Forget to Take Yasnal
If you forget to take your medicine, take the next dose at the usual time. Do not take a double dose to make up for the forgotten dose.
If you forget to take your medicine for more than one week, call your doctor before taking any more tablets.
If You Stop Taking Yasnal
Do not stop taking the tablets unless your doctor tells you to. If you stop taking Yasnal, the benefits of the treatment will gradually decrease.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
How Long to Take Yasnal
Your doctor or pharmacist will advise you on how long to continue taking the tablets. You will need to see your doctor from time to time to review your treatment and assess your symptoms.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects have been reported with Yasnal.
Tell your doctor if you have any of these side effects while taking Yasnal.
Serious Side Effects:
If you notice any of these serious side effects, tell your doctor immediately. You may need urgent medical treatment.
Frequency not known
Other Side Effects
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1,000 people):
Frequency not known (cannot be estimated from the available data):
Reporting of Side Effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet. You can also report side effects directly to the Spanish Medicines and Healthcare Products Agency (AEMPS) through the website www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the packaging after "EXP". The expiry date refers to the last day of the month shown.
This medicine does not require any special storage precautions.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to your pharmacist. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Yasnal
Each film-coated tablet contains 10 mg of hydrochloride (as monohydrate) of donepezil, equivalent to 9.12 mg of donepezil
See section 2 "Yasnal contains lactose".
Appearance of the Product and Packaging
The 10 mg film-coated tablets are yellowish-brown, round, biconvex, approximately 9 mm in diameter
Yasnal 10 mg is available in packs containing:
Not all pack sizes may be marketed.
Marketing Authorisation Holder:
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Manufacturer:
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
or
TAD Pharma GmbH, Heinz Lohmann strasse, 5 - Groden Cuxhaven - D-27472 - Germany
You can ask for more information about this medicine from the local representative of the Marketing Authorisation Holder:
KRKA Farmacéutica, S.L., C/ Anabel Segura 10, 28108 Alcobendas, Madrid, Spain
This medicine is authorised in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland)under the following names:
Member State | Medicine Name |
Germany, Bulgaria, Slovakia, Spain, Italy, Hungary, Czech Republic, Romania | Yasnal |
Greece | Donepezil/Krka |
Austria, Belgium, Cyprus, Denmark, France, Finland, Ireland, Sweden, Norway | Donepezil Krka |
Portugal | Donepezilo Krka |
United Kingdom (Northern Ireland) | Donepezil hydrochloride |
Date of Last Revision of this Package Leaflet: December 2022
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) (http://www.aemps.gob.es/)